BeiGene, Ltd. (29)

Browse by Contract Category

Contracts

Consulting Agreement, dated February 24, 2021, by and between the Registrant and Xiaodong Wang (Filed With SEC on February 25, 2021)
Description of BeiGene, Ltd.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 25, 2021)
Amendment No. 1 to Registration Rights Agreement, dated December 1, 2020, between the Company and the Investors (Filed With SEC on December 2, 2020)
Collaboration Agreement, dated October 31, 2019, by and among the Registrant, BeiGene Switzerland GmbH and Amgen Inc (Filed With SEC on March 2, 2020)
Underwriting Agreement, dated as of December 1, 2020, by and among the Company, the Selling Shareholders and Goldman Sachs & Co. LLC, as the representative of the several... (Filed With SEC on December 2, 2020)
Restated Amendment No. 2 to Share Purchase Agreement, dated September 2 (Filed With SEC on September 24, 2020)
Form of Global Non-Qualified Share Option Agreement for Non-Employee Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)
Form of Global Non-Qualified Share Option Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)
Form of Global Non-Qualified Share Option Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)
Form of Global Restricted Share Unit Award Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)
Form of Global Restricted Share Unit Award Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 6, 2020)
Form of Share Purchase Agreement (Filed With SEC on July 13, 2020)
Amendment No. 1 to the Second Amended and Restated 2019 Share Option and Incentive Plan (Filed With SEC on June 17, 2020)
Independent Director Compensation Policy, as amended (Filed With SEC on May 11, 2020)
Employment Apportionment Agreement, dated March 1, 2020, by and between BeiGene (Beijing) Co., Ltd., BeiGene Guangzhou Biologics Manufacturing Co., Ltd. and Xiaobin Wu (Filed With SEC on May 11, 2020)
Amendment No. 2 to Share Purchase Agreement, dated March 17, 2020, by and between Amgen Inc. and the Company (Filed With SEC on March 17, 2020)
Assignment and Assumption Agreement, dated December 29, 2017, by and between the Registrant and BeiGene Switzerland GmbH (Filed With SEC on March 2, 2020)
Guarantee, dated October 31, 2019, made by and between Amgen Inc. and the Registrant (Filed With SEC on March 2, 2020)
Amendment No. 1 to Share Purchase Agreement, dated December 6, 2019, by and between Amgen Inc. and the Registrant (Filed With SEC on March 2, 2020)
Share Purchase Agreement, dated October 31, 2019, by and between Amgen Inc. and the Registrant (Filed With SEC on March 2, 2020)
Description of BeiGene, Ltd.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 2, 2020)
Form of Global Non-Qualified Share Option Agreement for Non-Employee Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)
Form of Global Non-Qualified Share Option Agreement for Non-Employee Directors under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)
Form of Global Non-Qualified Share Option Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)
Form of Global Restricted Share Unit Award Agreement for Consultants under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)
Form of Global Restricted Share Unit Award Agreement for Employees under the Second Amended and Restated 2016 Share Option and Incentive Plan (Filed With SEC on August 8, 2019)
Letter Agreement, dated June 14, 2019, by and among the Registrant, BeiGene Switzerland GmbH, Celgene Corporation and Celgene Switzerland LLC, to terminate the Amended and... (Filed With SEC on August 8, 2019)
Amendment No. 1 to the Second Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on June 5, 2019)
BeiGene, Ltd. Independent Director Compensation Policy, as amended (Filed With SEC on June 5, 2019)